Pharmacodynamic Studies of Fluorescent Diamond Carriers of Doxorubicin in Liver Cancer Cells and Colorectal Cancer Organoids

por Firestein, Ron, Marcinkiewicz, Cezary, Nie, Linyan, Chua, Hui Kheng, Velazquez Quesada, Ines, Torelli, Marco, Sternberg, Mark, Gligorijevic, Bojana, Shenderova, Olga, Schirhagl, Romana, Feuerstein, Giora Z
Publicado 2021

Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells

por Aguirre-Alvarado, Charmina, Segura-Cabrera, Aldo, Velázquez-Quesada, Inés, Hernández-Esquivel, Miguel A., García-Pérez, Carlos A., Guerrero-Rodríguez, Sandra L., Ruiz, Angel J., Rodríguez-Moreno, Andrea, Pérez-Tapia, Sonia M., Velasco-Velázquez, Marco A.
Publicado 2016

Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells

por Velázquez-Quesada, Inés, Ruiz-Moreno, Angel J, Casique-Aguirre, Diana, Aguirre-Alvarado, Charmina, Cortés-Mendoza, Fabiola, de la Fuente-Granada, Marisol, García-Pérez, Carlos, Pérez-Tapia, Sonia M, González-Arenas, Aliesha, Segura-Cabrera, Aldo, Velasco-Velázquez, Marco A
Publicado 2020

Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression

por Murdamoothoo, Devadarssen, Sun, Zhen, Yilmaz, Alev, Riegel, Gilles, Abou‐Faycal, Chérine, Deligne, Claire, Velazquez‐Quesada, Ines, Erne, William, Nascimento, Marine, Mörgelin, Matthias, Cremel, Gérard, Paul, Nicodème, Carapito, Raphael, Veber, Romain, Dumortier, Hélène, Yuan, Jingping, Midwood, Kim S, Loustau, Thomas, Orend, Gertraud
Publicado 2021